Production & Manufacturing
Business & Industry
Cold Chain and Temperature-Controlled Laboratory Equipment in Pharmaceutical Research and Development
Temperature-sensitive biologics, advanced therapeutics, and pharmaceutical research materials demand specialized cold storage infrastructure spanning ultra-low temperature freezers, controlled-rate freezing systems, and validated stability chambers that maintain precise thermal conditions throughout research, development and testing workflows.
News
Celltrion Eyes Full-Scale Contract Manufacturing Operations
Celltrion on January 02, 2026, announced that it has completed the transfer of the biopharmaceutical production facility of Eli Lilly that’s located in Branchburg, New Jersey, and is now entering full-scale contract manufacturing operations - CMO when it comes...
Business & Industry
Continuous Manufacturing Equipment: Adoption Barriers and Industry Readiness
While continuous manufacturing offers efficiency and quality benefits, high capital costs and technical barriers like PAT integration, feeder accuracy, and RTD modeling slow its widespread adoption in pharma.
Business & Industry
Sustainable Laboratory Equipment Innovations Supporting Green Pharma Initiatives
As the pharmaceutical industry strives for carbon neutrality, the laboratory has become a focal point for sustainability efforts. This article highlights the latest innovations in eco-friendly equipment, from ultra-low temperature freezers to solvent recovery systems, demonstrating how green technology can reduce environmental impact without compromising scientific rigor.
BioPharma
Largest Vaccine Manufacturing Facility in Egypt Launched
Egypt has gone on to mark quite a prominent milestone when it comes to its biopharmaceutical development by laying the foundation stone for the GENNVAX vaccine manufacturing facility, which is all set to become the largest fully integrated vaccine...
Drug Research
UK Plans to Produce Cancer Treatment from Nuclear Waste
Bicycle Therapeutics has entered into a 15-year agreement with the UK Nuclear Decommissioning Authority (NDA) to utilize reprocessed uranium from nuclear reactors for the production of precision cancer therapies.
Under the terms of the deal, announced by the UK government,...
News
Pfizer Signs Around $2.1bn Licensing Deal with YaoPharma
Pfizer has confirmed that it has struck an almost $2.1bn licensing deal with YaoPharma in order to develop as well as commercialize its obesity pill, hence furthering its push into the weight loss spectrum.
It is worth noting that the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















